• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TELIGEN; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TELIGEN; IMPLANTABLE DEVICE Back to Search Results
Model Number F102
Device Problems Device Alarm System (1012); Premature Discharge of Battery (1057)
Patient Problem Anxiety (2328)
Event Date 12/04/2021
Event Type  Injury  
Event Description
It was reported that this device recorded a code 1003 indicative of battery voltage too low for the projected remaining capacity.A request was made to have data from this device analyzed and data analysis showed the battery appeared to be depleting more quickly than expected.At the previous interrogation, device longevity was two years and the current longevity was three months.It was noted that the patient also had a left-ventricular assist device in place.The device was emitting tones every six hours, which was causing stress and anxiety for the patient.Technical services discussed that the tones emitted from the device with respect to this condition are not a programmable feature.It was not planned to replace the device as the patient was placed on the heart transplant list.When eventually explanted, the device is expected to be returned to boston scientific for analysis.
 
Manufacturer Narrative
The returned implantable cardioverter defibrillator was analyzed and it was confirmed that the device recorded code 1003.An engineering-level longevity prediction calculation was completed to assess the rate of battery depletion.Given the programmed parameters and other data stored within the memory of the device, the results of this calculation indicated that the actual rate of battery depletion fell within an acceptable range.Boston scientific has concluded that this device experienced normal battery depletion.
 
Event Description
It was reported that this device recorded a code 1003 indicative of battery voltage too low for the projected remaining capacity.A request was made to have data from this device analyzed and data analysis showed the battery appeared to be depleting more quickly than expected.At the previous interrogation, device longevity was two years and the current longevity was three months.It was noted that the patient also had a left-ventricular assist device in place.The device was emitting tones every six hours, which was causing stress and anxiety for the patient.Technical services discussed that the tones emitted from the device with respect to this condition are not a programmable feature.It was not planned to replace the device as the patient was placed on the heart transplant list.When eventually explanted, the device is expected to be returned to boston scientific for analysis.It was additionally reported that the device was replaced.Boston scientific has received the device for analysis.
 
Event Description
It was reported that this device recorded a code 1003 indicative of battery voltage too low for the projected remaining capacity.A request was made to have data from this device analyzed and data analysis showed the battery appeared to be depleting more quickly than expected.At the previous interrogation, device longevity was two years and the current longevity was three months.It was noted that the patient also had a left-ventricular assist device in place.The device was emitting tones every six hours, which was causing stress and anxiety for the patient.Technical services discussed that the tones emitted from the device with respect to this condition are not a programmable feature.It was not planned to replace the device as the patient was placed on the heart transplant list.When eventually explanted, the device is expected to be returned to boston scientific for analysis.It was additionally reported that the device was replaced.Boston scientific has received the device for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TELIGEN
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key13445414
MDR Text Key285220177
Report Number2124215-2021-40877
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/06/2012
Device Model NumberF102
Device Catalogue NumberF102
Device Lot Number113933
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/10/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-